Literature DB >> 2153462

The progesterone receptor stimulates cell-free transcription by enhancing the formation of a stable preinitiation complex.

L Klein-Hitpass1, S Y Tsai, N L Weigel, G F Allan, D Riley, R Rodriguez, W T Schrader, M J Tsai, B W O'Malley.   

Abstract

Highly purified chicken progesterone receptor (cPR) is shown to stimulate RNA synthesis directly in an in vitro transcription assay. Stimulation of transcription by cPR requires the presence of progesterone response elements (PREs) in the template and can be specifically inhibited by addition of competitor oligonucleotides containing PREs. Binding of receptor to two PREs is cooperative and leads to synergistic (27-fold) stimulation of transcription. A purified fusion protein containing the DNA binding domain of cPR linked to yeast ubiquitin was produced in E. coli and also functions in the transcription assay. Using this in vitro transcription system, we demonstrate that hormone-free cPR activated by salt treatment induces transcription of a test gene in a hormone-independent manner. Finally, we present evidence that the progesterone receptor acts by facilitating the formation of a stable preinitiation complex at the target gene promoter and thus augments the initiation of transcription by RNA polymerase II.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2153462     DOI: 10.1016/0092-8674(90)90740-6

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  57 in total

1.  Steroid receptor induction of gene transcription: a two-step model.

Authors:  G Jenster; T E Spencer; M M Burcin; S Y Tsai; M J Tsai; B W O'Malley
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

2.  The transcriptionally-active MMTV promoter is depleted of histone H1.

Authors:  E H Bresnick; M Bustin; V Marsaud; H Richard-Foy; G L Hager
Journal:  Nucleic Acids Res       Date:  1992-01-25       Impact factor: 16.971

Review 3.  Activation of progestin receptors in female reproductive behavior: Interactions with neurotransmitters.

Authors:  Shaila Mani; Wendy Portillo
Journal:  Front Neuroendocrinol       Date:  2010-01-29       Impact factor: 8.606

4.  Synergistic transcriptional activation by CTF/NF-I and the estrogen receptor involves stabilized interactions with a limiting target factor.

Authors:  E Martinez; Y Dusserre; W Wahli; N Mermod
Journal:  Mol Cell Biol       Date:  1991-06       Impact factor: 4.272

5.  Two types of antiprogestins identified by their differential action in transcriptionally active extracts from T47D cells.

Authors:  L Klein-Hitpass; A C Cato; D Henderson; G U Ryffel
Journal:  Nucleic Acids Res       Date:  1991-03-25       Impact factor: 16.971

6.  Role of H1 phosphorylation in rapid GR exchange and function at the MMTV promoter.

Authors:  Diana A Stavreva; James G McNally
Journal:  Histochem Cell Biol       Date:  2005-11-17       Impact factor: 4.304

7.  The A and B isoforms of the human progesterone receptor operate through distinct signaling pathways within target cells.

Authors:  D X Wen; Y F Xu; D E Mais; M E Goldman; D P McDonnell
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

8.  Inhibition of human immunodeficiency virus type 1 transcription and replication by DNA sequence-selective plant lignans.

Authors:  J N Gnabre; J N Brady; D J Clanton; Y Ito; J Dittmer; R B Bates; R C Huang
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

9.  A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo.

Authors:  R Morishita; G H Gibbons; M Horiuchi; K E Ellison; M Nakama; L Zhang; Y Kaneda; T Ogihara; V J Dzau
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

10.  Analysis of estrogen receptor transcriptional enhancement by a nuclear hormone receptor coactivator.

Authors:  E M McInerney; M J Tsai; B W O'Malley; B S Katzenellenbogen
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.